Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$18.2 - $76.12 $789,880 - $3.3 Million
-43,400 Reduced 33.91%
84,600 $1.54 Million
Q3 2022

Nov 14, 2022

SELL
$18.2 - $76.12 $789,880 - $3.3 Million
-43,400 Reduced 33.91%
84,600 $1.54 Million
Q2 2022

Sep 21, 2023

BUY
$36.28 - $75.29 $4.28 Million - $8.88 Million
118,000 Added 1180.0%
128,000 $6.58 Million
Q2 2022

Aug 15, 2022

BUY
$36.28 - $75.29 $4.28 Million - $8.88 Million
118,000 Added 1180.0%
128,000 $6.58 Million
Q1 2022

Sep 21, 2023

BUY
$69.73 - $142.9 $348,650 - $714,500
5,000 Added 100.0%
10,000 $736,000
Q1 2022

May 16, 2022

BUY
$69.73 - $142.9 $348,650 - $714,500
5,000 Added 100.0%
10,000 $737,000
Q2 2021

Sep 21, 2023

SELL
$121.0 - $257.67 $992,200 - $2.11 Million
-8,200 Reduced 62.12%
5,000 $1.06 Million
Q2 2021

Aug 20, 2021

SELL
$121.0 - $257.67 $59.9 Million - $128 Million
-495,000 Reduced 99.0%
5,000 $1.06 Million
Q2 2021

Aug 16, 2021

BUY
$121.0 - $257.67 $58.9 Million - $125 Million
486,800 Added 3687.88%
500,000 $1.06 Million
Q1 2021

Sep 21, 2023

SELL
$112.98 - $319.93 $8.07 Million - $22.8 Million
-71,400 Reduced 84.4%
13,200 $2.39 Million
Q1 2021

May 14, 2021

BUY
$112.98 - $319.93 $361,536 - $1.02 Million
3,200 Added 32.0%
13,200 $2.39 Million
Q2 2020

Aug 14, 2020

BUY
$13.86 - $83.61 $138,600 - $836,100
10,000 New
10,000 $834,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $630M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.